| Date Filed | Type | Description |
| 07/28/2022 |
3
| Claiborne Cary J (Director) has filed a Form 3 on CYTRX CORP |
| 01/12/2022 |
4
| Snowdy Stephen (CEO) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 300,000 rights
@ $0.641, valued at
$192.3k
|
|
| 01/12/2022 |
3
| Snowdy Stephen (CEO) has filed a Form 3 on CYTRX CORP |
| 01/11/2022 |
4/A
| Simpson Jennifer K. (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 50,000 options to buy
@ $0.45, valued at
$22.5k
|
|
| 12/17/2021 |
4
| Simpson Jennifer K. (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 25,000 shares
@ $0 |
|
| 08/11/2021 |
3
| Simpson Jennifer K. (Director) has filed a Form 3 on CYTRX CORP |
| 08/20/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2019 |
4
| KRIEGSMAN STEVEN A (CEO) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 3,000,000 options to buy
@ $0.26, valued at
$780k
|
|
| 12/17/2019 |
4
| IGNARRO LOUIS (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 700,000 options to buy
@ $0.26, valued at
$182k
|
|
| 12/17/2019 |
4
| CALOZ JOHN Y (CFO) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 350,000 options to buy
@ $0.26, valued at
$91k
|
|
| 12/17/2019 |
4
| Caldwell Joel K (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 450,000 options to buy
@ $0.26, valued at
$117k
|
|
| 12/17/2019 |
4
| Brien Earl W (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 450,000 options to buy
@ $0.26, valued at
$117k
|
|
| 05/21/2018 |
3
| Curtis Eric (Pres., COO) has filed a Form 3 on CYTRX CORP |
| 01/02/2018 |
4
| Kratz Felix (Vice President Drug Discovery) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 25,000 options to buy
@ $1.75, valued at
$43.8k
|
|
| 01/02/2018 |
3
| Kratz Felix (Vice President Drug Discovery) has filed a Form 3 on CYTRX CORP |
| 12/19/2017 |
4
| IGNARRO LOUIS (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 30,000 options to buy
@ $1.75, valued at
$52.5k
|
|
| 12/19/2017 |
4
| CALOZ JOHN Y (CFO) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 58,334 options to buy
@ $1.75, valued at
$102.1k
|
|
| 12/19/2017 |
4
| Caldwell Joel K (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 30,000 options to buy
@ $1.75, valued at
$52.5k
|
|
| 12/19/2017 |
4
| Brien Earl W (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 70,000 options to buy
@ $1.75, valued at
$122.5k
|
|
| 12/19/2017 |
4
| KRIEGSMAN STEVEN A (CEO) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 387,597 shares
@ $1.75, valued at
$678.3k
Granted 208,334 options to buy
@ $1.75, valued at
$364.6k
|
|
| 09/06/2017 |
4
| Caldwell Joel K (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 180,000 options to buy
@ $0.67, valued at
$120.6k
|
|
| 09/06/2017 |
3
| Caldwell Joel K (Director) has filed a Form 3 on CYTRX CORP |
| 06/20/2017 |
3
| Chawla Shanta M.D. (Senior VP-Drug Development) has filed a Form 3 on CYTRX CORP |
| 12/20/2016 |
4
| KRIEGSMAN STEVEN A (CEO) has filed a Form 4 on CYTRX CORP |
| 12/19/2016 |
4
| LEVITT DANIEL J (EVP and Chief Medical Officer) has filed a Form 4 on CYTRX CORP |
| 12/19/2016 |
4
| Wieland Douglas Scott (Sr VP - Drug Development) has filed a Form 4 on CYTRX CORP |
| 12/19/2016 |
4
| CALOZ JOHN Y (CFO) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 350,000 options to buy
@ $0.43, valued at
$150.5k
|
|
| 12/19/2016 |
4
| KRIEGSMAN STEVEN A (CEO) has filed a Form 4 on CYTRX CORP |
| 12/19/2016 |
4
| RUBINFELD JOSEPH (Director) has filed a Form 4 on CYTRX CORP |
| 12/19/2016 |
4
| IGNARRO LOUIS (Director) has filed a Form 4 on CYTRX CORP|
Txns:
| Granted 180,000 options to buy
@ $0.43, valued at
$77.4k
|
|
| 12/19/2016 |
4
| Chawla Anita J (Director) has filed a Form 4 on CYTRX CORP |
|